Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
about
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibioticsRibosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acidHow beta-lactam antibiotics enter bacteria: a dialogue with the porinsNew antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitorsThe binding mode of second-generation sulfonamide inhibitors of MurD: clues for rational design of potent MurD inhibitorsPseudomonas aeruginosa PA1006 is a persulfide-modified protein that is critical for molybdenum homeostasisA thermostable Salmonella phage endolysin, Lys68, with broad bactericidal properties against gram-negative pathogens in presence of weak acidsBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaCould chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.New disturbing trend in antimicrobial resistance of gram-negative pathogensVirtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligaseA novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membraneHospital-acquired infections due to gram-negative bacteria.Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi ArabiaIn silico identification of common putative drug targets in Leptospira interrogansThe enzymes of β-lactam biosynthesis.Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead.The "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammationFrom microbial gene essentiality to novel antimicrobial drug targetsSynthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa.Prevalence of Device-associated Nosocomial Infections Caused By Gram-negative Bacteria in a Trauma Intensive Care Unit in Libya.Crystallization and preliminary diffraction studies of SFC-1, a carbapenemase conferring antibiotic resistance.Antibacterial and antibiotic resistance modulatory activities of leaves and bark extracts of Recinodindron heudelotii (Euphorbiaceae) against multidrug-resistant Gram-negative bacteria.Development of new 5-(chromene-3-yl)methylene-2,4-thiazolidinediones as antimicrobial agents.Design, Synthesis and Evaluation of Triazole-Pyrimidine Analogues as SecA Inhibitors.Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian.The growing resistance of Klebsiella pneumoniae; the need to expand our antibiogram: case report and review of the literature.Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionGenome Sequence of Bacteriophage GG32, Which Can Infect both Salmonella enterica Serovar Typhimurium and Escherichia coli O157:H7Targeting bacterial adherence inhibits multidrug-resistant Pseudomonas aeruginosa infection following burn injuryChanges in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria.Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.Antibacterial effect and proteomic analysis of graphene-based silver nanoparticles on a pathogenic bacterium Pseudomonas aeruginosa.Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity.Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria.
P2860
Q26783545-CD660F55-5DA1-49E1-9D27-7A88964B1721Q27677114-89093212-F7EC-442C-A07F-544B0D4DAC47Q28475476-A6A04EE0-62D4-4F83-826F-1AF655CC03A0Q28475848-AB3956E9-AFCA-4413-94FC-D53E8F7C24D4Q28484507-2D71F646-211A-45C4-9709-126C3E6D4287Q28486100-CFB9F353-6B66-442F-A2C9-A87B68C4E88BQ28543574-5D564D4F-79EB-4278-A093-4BDE834C322AQ29616084-9958522E-25C9-4B7C-A1E1-1E76E5C4D581Q30726683-7441E688-3FCC-4EC2-A959-AC7E94B5DF52Q33422956-A3FEC1B5-104D-48CA-85B3-B94C943DD7F2Q33897752-C4F464A5-5D9A-43EA-8E34-D322F5F2954EQ34045186-990C3BF8-4469-4B31-ADC8-C7F1A5838493Q34114983-AEC3DA19-416C-4485-A836-C21D3D896AFEQ34136100-924BD3E9-DD8B-42CD-9F01-75AEB5F15FB2Q34215398-7FFAF6CA-129D-4224-A564-53C65AB9D799Q34310470-1C565E5E-5887-4F9D-B0FC-AE68082EBB74Q34357575-8218B5E1-49FC-4286-B18B-5955E102A332Q34374054-25D4A216-E08B-4B36-86BD-1AC9861BDEA9Q34517482-9B8BB12F-C405-4965-91E9-A3C1387E2131Q35021444-36E2E7C4-7410-4231-81DD-265A8D7DB2FCQ35757930-519AA345-DA60-437B-9635-6FE7F3F86AE0Q36033050-E7DC02BE-1311-4DB2-9713-C13EE6100D01Q36206767-0979D926-30D3-4551-81F1-FE635791793EQ36322582-0C8C4CBE-CC7A-49FE-9D4A-A3E31251F6BCQ36649317-6713E80B-6A1A-4CA5-A20B-5931EED07CF6Q36652863-35927574-87AA-4607-9339-D4FE76F4811EQ36791550-049BCB31-B588-4C0C-A98C-12785B19FC32Q36825533-F46C1127-ABA4-4AAE-9088-7C98FEC87A05Q37287855-D6F64D76-13D8-4D19-BFF5-4E99E3D14FAFQ37487101-52E27468-5D4B-4102-8789-A85382935E14Q37518925-68E5ADBB-2160-4572-A825-DD319B0227EBQ37760510-4167B76B-6243-4AF0-B4F5-A8FA5710AD0AQ37767653-36256430-1530-4244-920D-1C1B88D8430AQ37872942-F88D6C60-2970-4918-BE8B-31E0F3F4D3C8Q37894832-6BC54192-80A1-4408-8421-E42E5FBD74C5Q38008459-81962BFB-AA2F-4321-A880-725FC6461951Q38475604-B07BD178-1792-4CA0-BDB6-C4ED8884C06CQ38646502-D414F8C9-66AC-459C-94A1-475C6429EAC1Q38793887-647F5051-6411-4999-9106-B178F60C00CCQ38810063-02CF7873-49C2-4112-98E6-0E55AB24F762
P2860
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en-gb
Treatment of health-care-assoc ...... cteria: a consensus statement.
@nl
type
label
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en-gb
Treatment of health-care-assoc ...... cteria: a consensus statement.
@nl
prefLabel
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en-gb
Treatment of health-care-assoc ...... cteria: a consensus statement.
@nl
P2093
P1476
Treatment of health-care-assoc ...... cteria: a consensus statement.
@en
P2093
Alex O'Neill
Christopher Schofield
Ian Chopra
Jean-Marie Frère
Lloyd Czaplewski
Mark Wilcox
Martin Everett
Mike Dawson
Patrice Courvalin
Uros Urleb
P304
P356
10.1016/S1473-3099(08)70018-5
P50
P577
2008-02-01T00:00:00Z